Clinical Trials Browser

Withdrawn × Lymphoma, Large B-Cell, Diffuse × pembrolizumab × Clear all

NCT03873025 2021-08-17

PLACARD

Phase 1/2 Withdrawn

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04279938 2020-02-21

A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL

Phase 1 Withdrawn

Recurrence, Lymphoma, Large B-Cell, Diffuse